Sangita Ghosh
Chief Tech/Sci/R&D Officer en CHEMOCENTRYX, INC. .
Perfil
Sangita Ghosh is a professional who has worked in various pharmaceutical companies.
She is currently the Senior Vice President-Technical Operations at ChemoCentryx, Inc. Prior to this, she worked as the Vice President-Pharmaceutical Development at Adamas Pharmaceuticals LLC from 2012 to 2018 and as the VP-Pharmaceutical Development & Manufacturing at Spruce Biosciences, Inc. from 2018 to 2020.
She also worked as a Senior Director at Transcept Pharma, Inc. She holds a doctorate degree from the Indian Institute of Science and a graduate degree from the Indian Institute of Technology Kanpur.
Cargos activos de Sangita Ghosh
| Empresas | Cargo | Inicio |
|---|---|---|
| CHEMOCENTRYX, INC. | Chief Tech/Sci/R&D Officer | 01/03/2020 |
Antiguos cargos conocidos de Sangita Ghosh.
| Empresas | Cargo | Fin |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/01/2020 |
| ADAMAS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2018 |
Transcept Pharma, Inc.
 Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | Director/Board Member | - |
Formación de Sangita Ghosh.
| Indian Institute of Science | Doctorate Degree |
| Indian Institute of Technology Kanpur | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SPRUCE BIOSCIENCES, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Sangita Ghosh
